✨ Free AI Report
Medartis Holding AG: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Medartis Holding AG
Company Research

Medartis Holding AG: Business Overview, Financials & Competitive Analysis

Medartis Holding AG scores 6/10 on the AskCyborg Cyborg Score (Solid). Specialist orthopedic implant manufacturer with established market position and niche focus, but facing pressures from larger competitors and profitability headwinds in recent periods. Medartis demonstrates stable fundamentals with ~CHF 244M annualized revenue run-rate, profitability (EBITDA margin 15.67%), and 949 employees across global operations. However, recent half-year net income turned.

What is Medartis Holding AG's industry? Medartis Holding AG (medartis.com) operates in Medical Device Manufacturing - Orthopedic Implants & Surgical Fixation. AskCyborg classifies Medartis Holding AG under Medical Device Manufacturing - Orthopedic Implants & Surgical Fixation in its company registry.

Medartis Holding AG is a specialized orthopedic medical device company that manufactures and distributes implants for surgical fixation of bone fractures and osteotomies. Founded in 1997 and headquartered in Basel, Sw...

6/ 10Solid

Cyborg Score thesis

Specialist orthopedic implant manufacturer with established market position and niche focus, but facing pressures from larger...

Read the full analyst-debate transcript →
Industry Medical Device Manufacturing - Orthopedic Implants & Surgical Fixation
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Medartis Holding AG Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Medartis Holding AG

AskCyborg analysts argue the bull and bear cases for Medartis Holding AG across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Medartis Holding AG OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Medartis Holding AG Overview

Pro stress-test →

Medartis Holding AG is a specialized orthopedic medical device company that manufactures and distributes implants for surgical fixation of bone fractures and osteotomies. Founded in 1997 and headquartered in Basel, Switzerland, the company serves the upper and lower extremities as well as craniomaxillofacial markets globally, with products distributed in over 50 countries.

Strategic Profile

Pro stress-test →

Medartis differentiates itself through proprietary titanium implant technology and precision surgical instruments, targeting specialized orthopedic surgeons and hospitals. The company leverages its established global distribution network across 13+ locations and focuses on innovation in fracture fixation solutions, positioning itself as a niche player in the premium orthopedic device sector.

Competitive Landscape

Pro stress-test →

Medartis competes against larger multinational orthopedic device manufacturers (Stryker, Zimmer Biomet, Smith & Nephew, DePuy Synthes) and specialized niche players. The company differentiates through titanium implant specialty, precision instruments, and focused geographic strength in Europe and selected international markets, but lacks the scale and R&D budgets of mega-cap competitors.

Industry Context

Medartis Holding AG operates in Medical Device Manufacturing - Orthopedic Implants & Surgical Fixation.

Key facts

Founded: 1997 · Headquarters: Basel, Switzerland · Employees: 949 · Revenue: CHF 244M (annualized) · Market cap: CHF 909M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Medartis Holding AG.

  • Recent operational profitability decline: H2 2025 net income swung negative to CHF -1.45M from prior-year positive CHF 963K, requiring management attention
  • Strategic growth through stake-building in complementary technologies: Increased ownership of Keri Medical SA to 47% in March 2023, diversifying product offerings
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • March 2023Capital increase of CHF 30 million completed to finance additional 18% stake in Keri Medical SA, increasing ownership to 47%
  • April 2022Senior convertible bond offering of CHF 125-150 million launched to strengthen financial flexibility following Nextremity Solutions acquisition
  • +1 moreTrack every material event for Medartis Holding AG as it happens. Explore monitoring →
Get alerted when Medartis Holding AG has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare Medartis Holding AG with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Medartis Holding AG operates in Medical Device Manufacturing - Orthopedic Implants & Surgical Fixation. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Device Manufacturing - Orthopedic Implants & Surgical Fixation research →
NEW · MCP server

Ask your AI assistant about Medartis Holding AG

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Medartis Holding AG and its top competitor on Cyborg Score”
“What did Medartis Holding AG do this quarter?”
“Is Medartis Holding AG a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Medartis Holding AG do?+
Medartis Holding AG is a specialized orthopedic medical device company that manufactures and distributes implants for surgical fixation of bone fractures and osteotomies. Founded in 1997 and headquartered in Basel, Sw...
What is Medartis Holding AG's Cyborg Score?+
Medartis Holding AG has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Medartis Holding AG's main competitors?+
Named competitors include Orthopedic Implant Systems, Trauma and Extremity Solutions, Titanium Implant Specialists, Craniomaxillofacial Solutions. The full competitive landscape is in the AskCyborg report.
How can I get the full Medartis Holding AG research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Medartis Holding AG research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Medartis Holding AG over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual